PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+34.81%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$152M
AUM Growth
+$152M
(+18%)
Cap. Flow
-$5.68M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
33.53%
Holding
141
New
15
Increased
30
Reduced
65
Closed
17
Top Buys
| 1 |
TEUM
Pareteum Corporation
TEUM
|
$1.71M |
| 2 |
Natera
NTRA
|
$1.47M |
| 3 |
Veritone
VERI
|
$1.27M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
$939K |
| 5 |
AbbVie
ABBV
|
$866K |
Top Sells
| 1 |
Abbott
ABT
|
$3.02M |
| 2 |
CareDx
CDNA
|
$2.08M |
| 3 |
Apyx Medical
APYX
|
$1.39M |
| 4 |
Vericel Corp
VCEL
|
$1.05M |
| 5 |
Intel
INTC
|
$976K |
Sector Composition
| 1 | Healthcare | 59.74% |
| 2 | Technology | 15.28% |
| 3 | Industrials | 5.82% |
| 4 | Communication Services | 5.78% |
| 5 | Consumer Discretionary | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vericel Corp
VCEL
$1.83B
| $8.5M | 5.59% | 485,150 -59,900 | -11% | -$1.05M |
|
2
Axogen
AXGN
$743M
| $7.35M | 4.84% | 349,125 -7,050 | -2% | -$148K |
|
|
TEUM
3
DELISTED
Pareteum Corporation
TEUM
| $6.12M | 4.03% | 1,345,407 +376,428 | +39% | +$1.71M |
|
4
NeoGenomics
NEO
$1.13B
| $5.42M | 3.57% | 264,650 -16,850 | -6% | -$345K |
|
5
Veracyte
VCYT
$2.39B
| $4.94M | 3.25% | 197,440 -11,265 | -5% | -$282K |
|
6
Standard BioTools
LAB
$481M
| $4.4M | 2.9% | 331,150 +6,350 | +2% | +$84.4K |
|
|
7
CareDx
CDNA
$727M
| $4.16M | 2.74% | 131,900 -66,060 | -33% | -$2.08M |
|
8
Magnite
MGNI
$3.7B
| $3.83M | 2.52% | 630,350 -16,400 | -3% | -$99.7K |
|
|
9
Abbott
ABT
$231B
| $3.13M | 2.06% | 39,154 -37,746 | -49% | -$3.02M |
|
|
CSII
10
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.08M | 2.03% | 79,650 -4,500 | -5% | -$174K |
|
11
Idexx Laboratories
IDXX
$51.8B
| $2.99M | 1.97% | 13,350 | – | – |
|
12
OptimizeRx
OPRX
$335M
| $2.72M | 1.79% | 213,961 -935 | -0.4% | -$11.9K |
|
13
Sensus Healthcare
SRTS
$55.7M
| $2.69M | 1.77% | 383,036 -1,800 | -0.5% | -$12.6K |
|
14
Eli Lilly
LLY
$657B
| $2.69M | 1.77% | 20,710 -2,900 | -12% | -$376K |
|
|
15
Natera
NTRA
$23.1B
| $2.68M | 1.76% | 129,900 +71,200 | +121% | +$1.47M |
|
16
Rockwell Medical
RMTI
$58.9M
| $2.53M | 1.67% | 445,300 +24,800 | +6% | +$141K |
|
17
Pfizer
PFE
$141B
| $2.53M | 1.66% | 59,449 -7,585 | -11% | -$322K |
|
18
ANI Pharmaceuticals
ANIP
$2.03B
| $2.3M | 1.51% | 32,550 -150 | -0.5% | -$10.6K |
|
19
Digital Turbine
APPS
$455M
| $2.29M | 1.51% | 654,895 -34,380 | -5% | -$120K |
|
20
CryoPort
CYRX
$444M
| $2.24M | 1.48% | 173,650 +25,750 | +17% | +$333K |
|
21
Microsoft
MSFT
$3.77T
| $2.09M | 1.38% | 17,710 -3,100 | -15% | -$366K |
|
22
LeMaitre Vascular
LMAT
$2.16B
| $1.89M | 1.24% | 60,900 -3,500 | -5% | -$109K |
|
23
AtriCure
ATRC
$1.84B
| $1.76M | 1.16% | 65,750 -10,000 | -13% | -$268K |
|
24
Tactile Systems Technology
TCMD
$297M
| $1.73M | 1.14% | 32,774 -1,531 | -4% | -$80.7K |
|
25
Champions Oncology
CSBR
$93.8M
| $1.71M | 1.13% | 174,700 | – | – |
|